Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary.

Clinical interventions in aging

Volumn 5, Issue , 2010, Pages 355-362

  Fisher, Alex ^a   Martin, Jodie ^b   Srikusalanukul, Wichat ^b   Davis, Michael ^b  

^a CANBERRA HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; ORGANOMETALLIC COMPOUND; STRONTIUM RANELATE; THIOPHENE DERIVATIVE;

AGED; ARTICLE; AUSTRALIA; BONE NECROSIS; CHEMICALLY INDUCED DISORDER; FEMALE; HIP FRACTURE; HUMAN; INCIDENCE; JAW DISEASE; MALE; MIDDLE AGED; OSTEOPOROSIS; PRESCRIPTION; PREVALENCE; STATISTICS;

AGED; AGED, 80 AND OVER; AUSTRALIAN CAPITAL TERRITORY; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; DRUG PRESCRIPTIONS; FEMALE; HIP FRACTURES; HUMANS; INCIDENCE; JAW DISEASES; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; OSTEONECROSIS; OSTEOPOROSIS; PREVALENCE; THIOPHENES;

MLCS; MLOWN;

EID: 79952635220     PISSN: None     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/cia.s13909     Document Type: Article

References (0)